JP2001031554A - Preparation for external use for skin - Google Patents
Preparation for external use for skinInfo
- Publication number
- JP2001031554A JP2001031554A JP11205831A JP20583199A JP2001031554A JP 2001031554 A JP2001031554 A JP 2001031554A JP 11205831 A JP11205831 A JP 11205831A JP 20583199 A JP20583199 A JP 20583199A JP 2001031554 A JP2001031554 A JP 2001031554A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- component
- preparation
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 claims abstract description 20
- 235000012000 cholesterol Nutrition 0.000 claims abstract description 10
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 9
- 239000003906 humectant Substances 0.000 claims abstract description 7
- 239000004973 liquid crystal related substance Substances 0.000 claims abstract description 7
- 239000000284 extract Substances 0.000 claims description 28
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 claims description 7
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 claims description 7
- 229940106189 ceramide Drugs 0.000 claims description 7
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 claims description 7
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 claims description 7
- 239000007787 solid Substances 0.000 claims description 6
- 235000017060 Arachis glabrata Nutrition 0.000 claims description 5
- 244000105624 Arachis hypogaea Species 0.000 claims description 5
- 235000010777 Arachis hypogaea Nutrition 0.000 claims description 5
- 235000018262 Arachis monticola Nutrition 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 235000020232 peanut Nutrition 0.000 claims description 5
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 4
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 4
- 230000000699 topical effect Effects 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 18
- 150000001875 compounds Chemical class 0.000 abstract description 2
- 229940052821 lupinus albus seed extract Drugs 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 12
- 239000000203 mixture Substances 0.000 description 10
- 206010013786 Dry skin Diseases 0.000 description 9
- 239000000126 substance Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- 239000000839 emulsion Substances 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000006210 lotion Substances 0.000 description 6
- -1 packs Substances 0.000 description 6
- 239000000843 powder Substances 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 240000000377 Tussilago farfara Species 0.000 description 5
- 235000004869 Tussilago farfara Nutrition 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 239000002674 ointment Substances 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- 244000144725 Amygdalus communis Species 0.000 description 4
- 235000011437 Amygdalus communis Nutrition 0.000 description 4
- 241000219745 Lupinus Species 0.000 description 4
- DATAGRPVKZEWHA-YFKPBYRVSA-N N(5)-ethyl-L-glutamine Chemical compound CCNC(=O)CC[C@H]([NH3+])C([O-])=O DATAGRPVKZEWHA-YFKPBYRVSA-N 0.000 description 4
- 235000020224 almond Nutrition 0.000 description 4
- 239000002537 cosmetic Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- 230000003020 moisturizing effect Effects 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 230000002335 preservative effect Effects 0.000 description 4
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- 240000000894 Lupinus albus Species 0.000 description 3
- 235000010649 Lupinus albus Nutrition 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 108091005804 Peptidases Proteins 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical class CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 229920002527 Glycogen Polymers 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 235000011034 Rubus glaucus Nutrition 0.000 description 2
- 244000235659 Rubus idaeus Species 0.000 description 2
- 235000009122 Rubus idaeus Nutrition 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- 244000273928 Zingiber officinale Species 0.000 description 2
- 235000006886 Zingiber officinale Nutrition 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000003599 detergent Substances 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 235000008397 ginger Nutrition 0.000 description 2
- 229940096919 glycogen Drugs 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000007721 medicinal effect Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 229960001153 serine Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 229940026510 theanine Drugs 0.000 description 2
- 238000005406 washing Methods 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 description 1
- LRPSCNBFQVBIDI-JNTOXOLQSA-N (20R,21S,22R)-20-amino-19,21,22-trihydroxyhexatriacontan-18-one Chemical compound C(CCCCCCCCCCCCCCCCC)(=O)C(O)[C@H](N)[C@H](O)[C@H](O)CCCCCCCCCCCCCC LRPSCNBFQVBIDI-JNTOXOLQSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- XZIIFPSPUDAGJM-UHFFFAOYSA-N 6-chloro-2-n,2-n-diethylpyrimidine-2,4-diamine Chemical compound CCN(CC)C1=NC(N)=CC(Cl)=N1 XZIIFPSPUDAGJM-UHFFFAOYSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000195940 Bryophyta Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 102100028314 Filaggrin Human genes 0.000 description 1
- 101710088660 Filaggrin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 235000021360 Myristic acid Nutrition 0.000 description 1
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 229940123973 Oxygen scavenger Drugs 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 230000006750 UV protection Effects 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000007844 bleaching agent Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 239000012459 cleaning agent Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 239000002826 coolant Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 229960003949 dexpanthenol Drugs 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 229940068998 egg yolk phospholipid Drugs 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 238000004299 exfoliation Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 229960002743 glutamine Drugs 0.000 description 1
- 235000004554 glutamine Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 229960002591 hydroxyproline Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 239000003410 keratolytic agent Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 235000011929 mousse Nutrition 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- DDOVBCWVTOHGCU-QMXMISKISA-N n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DDOVBCWVTOHGCU-QMXMISKISA-N 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 239000010466 nut oil Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 235000021110 pickles Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229960002429 proline Drugs 0.000 description 1
- 235000013930 proline Nutrition 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 239000013535 sea water Substances 0.000 description 1
- 235000004400 serine Nutrition 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229940035044 sorbitan monolaurate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 229940083466 soybean lecithin Drugs 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 description 1
- 229940074410 trehalose Drugs 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 229920003169 water-soluble polymer Polymers 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、優れた肌荒れ改善
効果を有する皮膚外用剤に関する。TECHNICAL FIELD The present invention relates to an external preparation for skin having an excellent effect of improving skin roughness.
【0002】[0002]
【従来の技術】従来より、乳液、クリーム、化粧水、パ
ック、分散液、洗浄料、軟膏、外用液等の皮膚外用剤に
は、これらに所定の薬効を付与することを目的として各
種の薬効成分が加えられている。例えば、肌荒れ改善を
目的としては、グリセリン、リン脂質、ムコ多糖、アロ
エ抽出物等の薬効成分が添加されている。2. Description of the Related Art Conventionally, skin external preparations such as emulsions, creams, lotions, packs, dispersions, cleansers, ointments, and external preparations have been used for various purposes in order to impart predetermined medicinal effects to them. Ingredients have been added. For example, for the purpose of improving skin roughness, medicinal ingredients such as glycerin, phospholipid, mucopolysaccharide, and aloe extract are added.
【0003】[0003]
【発明が解決しようとする課題】しかしながら、これら
の薬効成分を単に含有した皮膚外用剤では、薬効成分の
効果が十分でなかったり、あるいは、薬効を得るのに十
分な量を添加すると安定性に欠けたり使用感が悪くなる
場合があり、その改善が望まれていた。However, skin external preparations simply containing these medicinal components do not have sufficient effects of the medicinal components or, if added in an amount sufficient to obtain the medicinal effects, may have poor stability. In some cases, chipping or feeling of use may be poor, and improvement has been desired.
【0004】[0004]
【課題を解決するための手段】本発明者らは、薬効成分
の効果を向上させるべく鋭意検討を行った結果、ハウチ
ワマメ種子抽出物と特定の液晶形成成分を組み合わせれ
ば、優れた肌荒れ改善効果を有する皮膚外用剤が得ら
れ、更にこのものに保湿剤を加えるとその効果がより優
れることを見出し、本発明を完成した。Means for Solving the Problems The present inventors have conducted intensive studies to improve the effect of the medicinal component, and as a result, it has been found that combining the extract of Hauchiwa-bean with a specific liquid crystal forming component provides an excellent effect of improving rough skin. Was obtained, and it was found that when a humectant was added thereto, the effect was more excellent, and the present invention was completed.
【0005】すなわち、本発明は、次の成分(A)及び
(B) (A)ハウチワマメ種子抽出物 (B)コレステロール、セラミド及びこれらの誘導体か
ら選ばれる一種又は二種以上と、リン脂質とから成る液
晶形成成分を含有することを特徴とする皮膚外用剤であ
り、さらには(C)成分として保湿剤を含有することを
特徴とする肌荒れ改善効果に優れた皮膚外用剤を提供す
るものである。[0005] That is, the present invention relates to the following components (A) and (B): (A) Extract of bean seeds (B) One or more selected from cholesterol, ceramide and derivatives thereof, and phospholipids The present invention provides a skin external preparation characterized by comprising a liquid crystal forming component, and further comprising a humectant as the component (C) and having an excellent skin roughness improving effect. .
【0006】[0006]
【発明の実施の形態】本発明の(A)成分であるハウチ
ワマメ種子抽出物は、マメ科に属する植物であって、例
えばハウチワマメ(学名Lupinus albus)
の種子の粉砕末に水を加えて抽出して得られるものであ
り、好ましくは水抽出時にタンパク分解酵素を加えて加
水分解して得られるものである。DETAILED DESCRIPTION OF THE INVENTION The component of the present invention, component A of the present invention, is a plant belonging to the family Leguminosae, and is, for example, a legume (Lupinus albus).
Is obtained by adding water to the pulverized powder of the seeds and extracting the water, and preferably obtained by adding a proteolytic enzyme during the water extraction and hydrolyzing.
【0007】好ましい調製方法の例としては、ハウチワ
マメ(学名Lupinus albus)の種子の粉砕
末に水とタンパク分解酵素を加えてて加水分解を行う。
得られた抽出液を低温にて2〜3日間放置した後、濾過
し、得られた濾液をさらに5日間ほど放置して熟成さ
せ、再び濾過を行う方法が挙げられる。[0007] As an example of a preferable preparation method, hydrolysis is performed by adding water and a proteolytic enzyme to the ground powder of the seeds of lupine (Lupinus albus).
After leaving the obtained extract at a low temperature for 2 to 3 days, filtration is performed, and the obtained filtrate is left to mature for about 5 days, and filtration is performed again.
【0008】本発明の(A)成分であるハウチワマメ種
子抽出物は、皮膚の天然保湿因子(NMF)の起源であ
るフィラグリンの生成を促進させるものであり、その含
有量は、全組成中乾燥固形分として好ましくは0.00
01〜5重量%(以下単に「%」で示す)、より好まし
くは0.001〜3%である。ハウチワマメ種子抽出物
の含有量がこの範囲であると、本発明の効果がより良く
発現する。[0008] The component of (A) of the present invention, a lupine bean seed extract, promotes the production of filaggrin, which is the source of the skin's natural moisturizing factor (NMF). Preferably 0.00
01 to 5% by weight (hereinafter simply referred to as "%"), more preferably 0.001 to 3%. The effect of the present invention is better exhibited when the content of the extract of the lupine seed is within this range.
【0009】本発明の(B)成分である液晶形成成分
は、コレステロール、セラミド及びこれらの誘導体から
選ばれる一種又は二種以上と、リン脂質とから成る。具
体的には、例えば以下に示すものが挙げられる。The liquid crystal forming component as the component (B) of the present invention comprises one or more selected from cholesterol, ceramide and derivatives thereof, and a phospholipid. Specifically, the following are mentioned, for example.
【0010】コレステロール及びその誘導体としては、
コレステロール、フィトステロール、ヒドロキシステア
リン酸コレステリル、ステアリン酸コレステリル、ポリ
オキシエチレン付加コレステロール、マカデミアンナッ
ツ油脂肪酸コレステリル、セラミド及びその誘導体とし
ては、ガラクトシルセラミド、グルコセラミド、ステア
ロイルフィトスフィンゴシン、リン脂質としては、卵黄
または大豆由来リン脂質およびその水素添加物等が挙げ
られる。As cholesterol and its derivatives,
As cholesterol, phytosterol, cholesteryl hydroxystearate, cholesteryl stearate, polyoxyethylene-added cholesterol, macadamian nut oil fatty acid cholesteryl, ceramide and derivatives thereof, galactosylceramide, glucoceramide, stearoyl phytosphingosine, phospholipid, egg yolk or And soybean-derived phospholipids and hydrogenated products thereof.
【0011】本発明の(B)成分の液晶形成成分は、水
をその構造内に抱え込み、肌へ水分を効率良く送り届け
る効果を有するものであり、その含有量は、全組成中好
ましくは0.0001〜5%であり、より好ましくは
0.0001〜3%である。液晶形成成分のうちリン脂
質の割合が50%以上であるとより顕著な効果が得られ
る。The liquid crystal-forming component (B) of the present invention has the effect of retaining water in its structure and efficiently delivering moisture to the skin. 0001-5%, more preferably 0.0001-3%. A more remarkable effect can be obtained when the proportion of the phospholipid in the liquid crystal forming component is 50% or more.
【0012】本発明の(C)成分である保湿剤は特に限
定されないが、例えば、グリシン、セリン、アスパラギ
ン酸、グルタミン酸、アスパラギン、グルタミン、プロ
リン、ハイドロキシプロリン、シトルリン、テアニン、
ピロリドンカルボン酸等のアミノ酸及びそれらの誘導
体、ソルビトール、エリスリトール、マルチトール、キ
シリトール、トレハロース、蔗糖、グリコーゲン等の糖
類及びその誘導体、D−パンテノール及びその誘導体、
アーモンド抽出物、フキタンポポ抽出物、ラズベリー抽
出物等の保湿効果を有する植物抽出物、クエン酸、乳
酸、グリコール酸等のα−ヒドロキシ酸、1,3−ブチ
レングリコール、グリセリン等のグリコール類、アルカ
リ単純温泉水、海洋深層水等が挙げられ、これらの一種
又は二種以上を適宜選択して用いることができる。The humectant as the component (C) of the present invention is not particularly limited. Examples thereof include glycine, serine, aspartic acid, glutamic acid, asparagine, glutamine, proline, hydroxyproline, citrulline, and theanine.
Amino acids such as pyrrolidonecarboxylic acid and derivatives thereof, sorbitol, erythritol, maltitol, xylitol, trehalose, sucrose, sugars such as glycogen and derivatives thereof, D-panthenol and derivatives thereof,
Plant extracts having a moisturizing effect such as almond extract, coltsfoot extract and raspberry extract, α-hydroxy acids such as citric acid, lactic acid and glycolic acid, glycols such as 1,3-butylene glycol and glycerin, and alkali simple Hot spring water, deep sea water and the like can be mentioned, and one or more of these can be appropriately selected and used.
【0013】本発明の(C)成分である保湿剤の含有量
は、好ましくは0.0001〜5%、より好ましくは
0.001〜3%である。抽出物は乾燥固形分としてこ
の範囲であればよい。本発明の(C)成分の保湿剤の含
有量がこの範囲であれば、(A)成分のハウチワマメ種
子抽出物及び(B)成分の液晶形成成分と組み合わせた
場合、本発明の皮膚外用剤中のハウチワマメ種子抽出物
及び液晶形成成分に影響を及ぼすことがなく、経時安定
性が良好で、より優れた肌荒れ改善効果を有する皮膚外
用剤が得られる。The content of the humectant as the component (C) of the present invention is preferably 0.0001 to 5%, more preferably 0.001 to 3%. The extract may be in this range as dry solids. When the content of the moisturizing agent of the component (C) of the present invention is within this range, when the extract is used in combination with the component (A) of the lupine seed extract and the component (B) of the liquid crystal forming component, the skin external preparation of the present invention will A skin external preparation having good stability over time and an excellent effect of improving skin roughness without affecting the extract of peanut seeds and liquid crystal-forming components.
【0014】本発明の皮膚外用剤の形態としては、特に
限定されず、例えば、乳液、クリーム、化粧水、パッ
ク、洗浄料等のスキンケア化粧料、口紅、ファンデーシ
ョン等のメーキャップ化粧料、頭皮用化粧料や、軟膏、
分散液、外用液剤等の医薬品などとすることができ、そ
の剤型についても特に制限はなく、固型状、ペースト
状、ムース状、ジェル状、粉末状、溶液系、可溶化系、
乳化系、粉末分散系、多層状とすることができる。The form of the external preparation for skin of the present invention is not particularly limited, and examples thereof include skin care cosmetics such as milky lotions, creams, lotions, packs, cleaning agents, makeup cosmetics such as lipsticks and foundations, and scalp cosmetics. Ingredients, ointments,
Dispersion, can be a drug such as a liquid for external use, etc., there is no particular limitation on the dosage form, solid, paste, mousse, gel, powder, solution, solubilization,
It can be emulsified, powder dispersed, or multilayer.
【0015】また、本発明の皮膚外用剤には、上記
(A)、(B)、(C)成分以外に、本発明の効果を損
なわない範囲で、通常、化粧料や医薬部外品、外用医薬
品等の製剤に使用される成分、すなわち、水、油剤、界
面活性剤、金属セッケン、ゲル化剤、粉体、アルコール
類、水溶性高分子、皮膜形成剤、樹脂、紫外線防御剤、
包接化合物、抗菌剤、香料、消臭剤、塩類、PH調整
剤、清涼剤、動物・微生物由来抽出物、植物抽出物、血
行促進剤、収斂剤、抗脂漏剤、活性酸素消去剤、細胞賦
活剤、美白剤、抗炎症剤、角質溶解剤、酵素、ホルモン
類、ビタミン類等を適宜加えることができる。In addition to the components (A), (B) and (C), the external preparation for skin of the present invention usually contains cosmetics, quasi-drugs, and the like, as long as the effects of the present invention are not impaired. Ingredients used in the preparation of topical medicines, such as water, oils, surfactants, metal soaps, gelling agents, powders, alcohols, water-soluble polymers, film-forming agents, resins, UV protection agents,
Clathrate compounds, antibacterial agents, fragrances, deodorants, salts, pH regulators, cooling agents, extracts from animals and microorganisms, plant extracts, blood circulation promoters, astringents, antiseborrheic agents, active oxygen scavengers, Cell activators, whitening agents, anti-inflammatory agents, keratolytic agents, enzymes, hormones, vitamins and the like can be added as appropriate.
【0016】[0016]
【実施例】次に参考例及び実施例を挙げて本発明を更に
詳細に説明するが、本発明はこれらになんら制約される
ものではない。EXAMPLES The present invention will be described in more detail with reference to Reference Examples and Examples, which should not be construed as limiting the present invention.
【0017】参考例1 ハウチワマメ種子抽出物の製造 ハウチワマメ(学名Lupinus albus)の種
子50gの粉砕末に精製水1Lとタンパク分解酵素を加
えて加水分解し、低温にて2〜3日間放置したのち濾過
し、得られた濾液をさらに5日間ほど放置して熟成さ
せ、再び濾過を行ってハウチワマメ種子抽出物を得た
(乾燥固形分5.0%)。REFERENCE EXAMPLE 1 Production of Ginger Seed Extract 1 g of purified water and 1 L of proteolytic enzyme were added to the ground powder of 50 g of ginger (Lupinus albus) seeds, hydrolyzed, left at low temperature for 2 to 3 days, and then filtered. Then, the obtained filtrate was left to mature for about 5 days, and then filtered again to obtain a pickle seed extract (dry solid content: 5.0%).
【0018】参考例2 アーモンド抽出物の製造 アーモンドの種子(甘へん桃)100gを細切後、精製
水100mlを加え、時々撹拌しながら室温で3日間抽
出し、濾過してアーモンド抽出物を得た(乾燥固形分
3.0%)。Reference Example 2 Preparation of Almond Extract 100 g of almond seeds (sweet peach) were cut into small pieces, 100 ml of purified water was added thereto, and the mixture was extracted at room temperature for 3 days with occasional stirring, followed by filtration to obtain an almond extract. (3.0% dry solids).
【0019】参考例3 フキタンポポ抽出物の製造 フキタンポポの花10gを細切し、50%1,3−ブチ
レングリコール50mlを加え、時々撹拌しながら室温
で7日間抽出し、濾過してフキタンポポ抽出物を得た
(乾燥固形分1.5%)。REFERENCE EXAMPLE 3 Preparation of coltsfoot extract A 10% coltsfoot flower was cut into pieces, 50 ml of 50% 1,3-butylene glycol was added, extracted at room temperature for 7 days with occasional stirring, and filtered to obtain a coltsfoot extract. (1.5% dry solids).
【0020】実施例1 乳液 表1に示す組成及び下記製法で乳液を調製し、その肌荒
れ改善効果を調べた。その結果も併せて表1に示す。Example 1 Emulsion Emulsion was prepared according to the composition shown in Table 1 and the following method, and the effect of improving skin roughness was examined. Table 1 also shows the results.
【0021】[0021]
【表1】 [Table 1]
【0022】*1 日光ケミカルズ社製 *2 和光純薬社製 *3 参考例1で製造したもの *4 味の素社製 *5 参考例2で製造したもの *6 参考例3で製造したもの* 1 Nikko Chemicals * 2 Wako Pure Chemical * 3 Manufactured in Reference Example 1 * 4 Ajinomoto Co. * 5 Manufactured in Reference Example 2 * 6 Manufactured in Reference Example 3
【0023】(製法) A.成分(1)〜(7)を混合し、加熱して70℃に保
つ。 B.成分(13)、(15)及び(16)の一部を混合
し、加熱して70℃に保つ。 C.AにBを加え、混合した後、冷却する。 D.Cに(8)〜(12)、(14)及び残りの(1
6)を加えて乳液を得た。(Production method) A. Components (1) to (7) are mixed and heated to 70 ° C. B. A portion of components (13), (15) and (16) are mixed and heated to 70 ° C. C. Add B to A, mix and cool. D. (8) to (12), (14) and the remaining (1)
6) was added to obtain an emulsion.
【0024】(試験方法)26〜44才の健常人15名
をパネルとし、実験的な肌荒れを惹起する前の肌状態を
ミクロスコープカメラで撮影し、下記基準によりそのス
コアを求めた。実験的な肌荒れは、上腕屈側部をエーテ
ル、アセトン(1:1)混液で処理することにより惹起
した。さらにその後は、14日間にわたって毎日、朝と
夜の2回被験乳液を塗布し、肌荒れ惹起の1、3、7及
び14日後に前記と同様肌状態のスコアを求めた。それ
らのスコアを平均して、肌荒れの改善効果を評価した。(Test Method) Fifteen healthy persons aged 26 to 44 years were used as panels, and the skin condition before experimental skin roughness was photographed with a microscope camera, and the score was determined according to the following criteria. Experimental rough skin was caused by treating the upper arm flexion side with a mixed solution of ether and acetone (1: 1). Thereafter, the test emulsion was applied twice a day, in the morning and at night, for 14 days, and scores of the skin condition were obtained in the same manner as described above 1, 3, 7 and 14 days after the occurrence of rough skin. The scores were averaged to evaluate the effect of improving skin roughness.
【0025】 [肌状態スコア] <スコア> <状 態> 1 肌の皮溝が不鮮明であり、角質のはがれが認められる。 2 肌の皮溝がやや不鮮明であるかまたは一方向性が強い。 3 肌の皮溝は認められるが、浅いかまたは一方向性が強い。 4 肌の皮溝が認められるかまたはやや網目状である。 5 肌の皮溝がはっきり認められるかまたはきれいな網目状である。[Skin Condition Score] <Score> <State> 1 Skin groove of skin is unclear and exfoliation of keratin is recognized. 2 Skin crevices are slightly unclear or strongly unidirectional. 3 Skin sulcus is recognized but shallow or strongly unidirectional. 4 Skin sulcus is recognized or slightly reticulated. 5 Skin crevices are clearly recognized or have a fine mesh.
【0026】表1の結果から明らかな如く、本発明品の
乳液は、比較品よりも優れた肌荒れ改善効果を有するも
のであった。As is evident from the results in Table 1, the emulsion of the product of the present invention had a better skin roughness improving effect than the comparative product.
【0027】 実施例2 化粧水 (処方) (%) (1)グリセリン 5.0 (2)1,3−ブチレングリコール 6.5 (3)水素添加大豆リン脂質*1 1.0 (4)コレステロール*2 0.5 (5)ポリオキシエチレン(20E.O.) ソルビタンモノラウリン酸エステル 1.2 (6)エチルアルコール 8.0 (7)ハウチワマメ種子抽出物*3 1.0 (8)L−セリン*4 0.5 (9)フキタンポポ抽出物*5 1.0 (10)防腐剤 適量 (11)香料 適量 (12)精製水 残量 *1 日光ケミカルズ社製 *2 和光純薬製 *3 参考例1で製造したもの *4 味の素社製 *5 参考例3で製造したものExample 2 Lotion (Formulation) (%) (1) Glycerin 5.0 (2) 1,3-butylene glycol 6.5 (3) Hydrogenated soybean phospholipid * 1 1.0 (4) Cholesterol * 2 0.5 (5) Polyoxyethylene (20EO) Sorbitan monolaurate 1.2 (6) Ethyl alcohol 8.0 (7) Extract of bean seeds * 3 1.0 (8) L-serine * 4 0.5 (9) Coltsfoot extract * 5 1.0 (10) Suitable amount of preservative (11) Suitable amount of fragrance (12) Remaining purified water * 1 Nikko Chemicals * 2 Wako Pure Chemical * 3 Reference Example * 4 Manufactured in Ajinomoto Co. * 5 Manufactured in Reference Example 3
【0028】(製法) A.成分(1)、(3)、(4)、(5)及び(10)
を加熱しながら混合溶解する。 B.成分(2)、(6)〜(9)、(11)及び(1
2)を混合溶解する。 C.AとBを混合して均一にし、化粧水を得た。(Production method) A. Components (1), (3), (4), (5) and (10)
And dissolve while heating. B. Components (2), (6) to (9), (11) and (1)
2) is mixed and dissolved. C. A and B were mixed and made uniform to obtain a lotion.
【0029】実施例2は、経時安定性に優れ、優れた肌
荒れ改善効果を有する化粧水であった。Example 2 was a lotion having excellent stability over time and an excellent effect of improving rough skin.
【0030】 実施例3 軟膏 (処方) (%) (1)ステアリン酸 18.0 (2)セタノール 4.0 (3)水素添加卵黄リン脂質*1 1.0 (4)ポリオキシエチレン付加コレステロール*2 0.5 (5)トリエタノールアミン 1.0 (6)セラミド*3 0.2 (7)グリセリン 5.0 (8)ハウチワマメ種子抽出物*4 0.2 (9)ラズベリー抽出物*5 0.3 (10)グリコーゲン*6 0.5 (11)防腐剤 適量 (12)アルカリ単純温泉水*7 残量 *1 旭化成社製 *2 日光ケミカルズ社製 *3 日光ケミカルズ社製 *4 参考例1で製造したもの *5 AMI社製 *6 キユーピー社製 *7 丸善製薬社製 Example 3 Ointment (Formulation) (%) (1) Stearic acid 18.0 (2) Cetanol 4.0 (3) Hydrogenated egg yolk phospholipid * 1 1.0 (4) Polyoxyethylene-added cholesterol * 2 0.5 (5) Triethanolamine 1.0 (6) Ceramide * 3 0.2 (7) Glycerin 5.0 (8) Dipterocarp seed extract * 4 0.2 (9) Raspberry extract * 50 .3 (10) Glycogen * 6 0.5 (11) Preservative appropriate amount (12) Alkaline simple hot spring water * 7 Remaining * 1 Asahi Kasei * 2 Nikko Chemicals * 3 Nikko Chemicals * 4 Reference Example 1 * 5 AMI Co., Ltd. * 6 KUPI Co., Ltd. * 7 Maruzen Pharmaceutical Co., Ltd.
【0031】(製法) A.成分(1)〜(4)、(6)及び(11)を(7)
に加熱溶解し、75℃に保つ。 B.成分(5)及び(12)の一部を加熱混合し、75
℃に保つ。 C.AをBに徐々に加える。 D.Cを冷却しながら残りの(12)で溶解した(8)
〜(10)を加え、軟膏を得た。(Production method) A. Components (1) to (4), (6) and (11) as (7)
And heat to 75 ° C. B. Heat and mix a part of components (5) and (12),
Keep at ° C. C. Add A slowly to B. D. C was dissolved in the remaining (12) while cooling (8)
To (10) was added to obtain an ointment.
【0032】実施例3は、肌荒れ改善効果に有効な軟膏
であった。Example 3 was an ointment effective for improving skin roughness.
【0033】 実施例4 パック (処方) (%) (1)ポリビニルアルコール 20.0 (2)エタノール 20.0 (3)グリセリン 5.0 (4)大豆レシチン*1 0.5 (5)フィトステロール*2 0.2 (6)カオリン 6.0 (7)ハウチワマメ種子抽出物*3 0.2 (8)防腐剤 適量 (9)香料 適量 (10)精製水 残量 *1 日光ケミカルズ社製 *2 エーザイ社製 *3 参考例1で製造したものExample 4 Pack (Formulation) (%) (1) Polyvinyl alcohol 20.0 (2) Ethanol 20.0 (3) Glycerin 5.0 (4) Soybean lecithin * 1 0.5 (5) Phytosterol * 2 0.2 (6) Kaolin 6.0 (7) Ginger peanut seed extract * 3 0.2 (8) Preservative appropriate amount (9) Flavor appropriate amount (10) Purified water remaining amount * 1 Nikko Chemicals * 2 Eisai * 3 Manufactured in Reference Example 1
【0034】(製法) A.成分(1)、(2)、(6)及び(10)を混合
し、70℃に加熱し、撹拌する。 B.成分(3)、(4)及び(5)を加熱し、混合す
る。 C.上記Bを先のAに加え、混合した後、冷却して
(7)、(8)及び(9)を均一に分散してパックを得
た。(Production method) A. Mix components (1), (2), (6) and (10), heat to 70 ° C. and stir. B. Heat and mix components (3), (4) and (5). C. The above B was added to the above A, mixed, cooled, and (7), (8) and (9) were uniformly dispersed to obtain a pack.
【0035】実施例4は、肌に潤いを付与するパックで
あった。Example 4 was a pack for providing moisture to the skin.
【0036】実施例5 洗浄料 (処方) (%) (1)ステアリン酸 10.0 (2)パルミチン酸 8.0 (3)ミリスチン酸 12.0 (4)ラウリン酸 4.0 (5)オレイルアルコール 1.5 (6)精製ラノリン 1.0 (7)卵黄レシチン*1 0.5 (8)セラミド*2 0.3 (9)香料 適量 (10)防腐剤 適量 (11)グリセリン 18.0 (12)水酸化カリウム 6.0 (13)ハウチワマメ種子抽出物*3 0.5 (14)テアニン*4 0.1 (15)精製水 残量 *1 旭化成社製 *2 日光ケミカルズ社製 *3 参考例1で製造したもの *4 太陽化学社製Example 5 Detergent (Formulation) (%) (1) Stearic acid 10.0 (2) Palmitic acid 8.0 (3) Myristic acid 12.0 (4) Lauric acid 4.0 (5) Oleyl Alcohol 1.5 (6) Purified lanolin 1.0 (7) Egg yolk lecithin * 1 0.5 (8) Ceramide * 2 0.3 (9) Fragrance appropriate amount (10) Preservative appropriate amount (11) Glycerin 18.0 ( 12) Potassium hydroxide 6.0 (13) Peanut seed extract * 3 0.5 (14) Theanine * 4 0.1 (15) Purified water balance * 1 Asahi Kasei * 2 Nikko Chemicals * 3 Reference Manufactured in Example 1 * 4 Taiyo Chemical Co., Ltd.
【0037】(製法) A.成分(11)、(12)及び(15)の一部を混合
し、70℃に加熱する。 B.成分(1)〜(8)及び(10)を混合し、70℃
に加熱する。 C.上記Bを先のAに加え、しばらく70℃に保ち、反
応が終了後、50℃まで冷却し、成分(9)、(13)
及び残りの(15)で溶解した(14)を加え、冷却し
て洗浄料を得た。(Production method) A. Mix part of components (11), (12) and (15) and heat to 70 ° C. B. Mix components (1) to (8) and (10),
Heat to C. The above B was added to the above A, and kept at 70 ° C. for a while. After the reaction was completed, the mixture was cooled to 50 ° C., and the components (9) and (13)
And the remaining (14) dissolved in (15) was added, and cooled to obtain a washing agent.
【0038】実施例5は、洗浄後の肌に潤いを付与し、
肌のかさつきを防止する洗浄料であった。In Example 5, the skin after washing was moisturized,
It was a cleansing agent that prevented the skin from becoming bulky.
【0039】[0039]
【発明の効果】本発明の皮膚外用剤はハウチワマメ種子
抽出物、及びコレステロール、セラミド及びこれらの誘
導体から選ばれる一種又は二種以上と、リン脂質とから
成る液晶形成成分を含有し、さらには保湿剤を含有する
ことにより、優れた肌荒れ改善効果を有するものであ
り、美容や医療において極めて有用なものである。EFFECTS OF THE INVENTION The skin preparation for external use of the present invention contains a liquid extract-forming component comprising an extract of peanut seeds, one or more selected from cholesterol, ceramide and derivatives thereof, and a phospholipid, and further has a moisturizing effect. By containing the agent, it has an excellent effect of improving rough skin and is extremely useful in beauty and medical treatment.
───────────────────────────────────────────────────── フロントページの続き (51)Int.Cl.7 識別記号 FI テーマコート゛(参考) A61K 35/78 A61K 35/78 J (72)発明者 森山 正大 東京都北区栄町48番18号 株式会社コーセ ー研究本部内 Fターム(参考) 4C083 AA082 AA111 AA112 AA162 AB032 AB442 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC442 AC542 AC582 AC641 AD112 AD352 AD412 AD491 AD492 AD512 AD571 AD572 BB51 CC02 CC04 CC05 CC07 CC23 DD22 DD23 DD31 EE12 FF01 FF05 4C088 AB26 AB52 AB59 ──────────────────────────────────────────────────の Continued on the front page (51) Int.Cl. 7 Identification FI FI Theme Court ゛ (Reference) A61K 35/78 A61K 35/78 J (72) Inventor Masahiro Moriyama 48-18 Sakaemachi, Kita-ku, Tokyo Co., Ltd. 4C083 AA082 AA111 AA112 AA162 AB032 AB442 AC012 AC022 AC072 AC102 AC122 AC182 AC242 AC442 AC542 AC582 AC641 AD112 AD352 AD412 AD491 AD492 AD512 AD571 AD572 BB51 CC02 CC04 CC05 CC07 CC23 DD22 DD23 DD01 FF31 AB AB52 AB59
Claims (5)
ら選ばれる一種又は二種以上と、リン脂質とから成る液
晶形成成分を含有することを特徴とする皮膚外用剤。1. A liquid crystal-forming component comprising the following components (A) and (B): (A) Extract of peanut seeds; (B) one or more selected from cholesterol, ceramide and derivatives thereof; and a phospholipid. An external preparation for skin, comprising:
含有量が乾燥固形分として0.0001〜5重量%であ
る請求項1記載の皮膚外用剤。2. The topical skin preparation according to claim 1, wherein the content of the component of (A), the pickled bean seed extract, is 0.0001 to 5% by weight as a dry solid content.
0.0001〜5重量%である請求項1又は2記載の皮
膚外用剤。3. The external preparation for skin according to claim 1, wherein the content of the liquid crystal forming component (B) is 0.0001 to 5% by weight.
することを特徴とする請求項1〜3のいずれか1項に記
載の皮膚外用剤。4. The external preparation for skin according to claim 1, further comprising a humectant as the component (C).
01〜5重量%である請求項4記載の皮膚外用剤。5. The content of the humectant of component (C) is 0.00
The external preparation for skin according to claim 4, wherein the amount is from 01 to 5% by weight.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11205831A JP2001031554A (en) | 1999-07-21 | 1999-07-21 | Preparation for external use for skin |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP11205831A JP2001031554A (en) | 1999-07-21 | 1999-07-21 | Preparation for external use for skin |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2001031554A true JP2001031554A (en) | 2001-02-06 |
Family
ID=16513444
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP11205831A Pending JP2001031554A (en) | 1999-07-21 | 1999-07-21 | Preparation for external use for skin |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2001031554A (en) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2001093855A1 (en) * | 2000-06-07 | 2001-12-13 | Otsuka Kagaku Kabushiki Kaisha | Skin-moistening compositions and skin-moistening foods |
| JP2007001950A (en) * | 2005-06-27 | 2007-01-11 | Pola Chem Ind Inc | Ceramide-containing skin external preparation |
| JP2008169219A (en) * | 2000-02-25 | 2008-07-24 | Kuhs Gmbh | Cosmetic composition |
| JP2013227294A (en) * | 2012-03-30 | 2013-11-07 | Kose Corp | Translucent to transparent composition |
| JP2017014202A (en) * | 2015-06-30 | 2017-01-19 | 株式会社コーセー | Cosmetic |
-
1999
- 1999-07-21 JP JP11205831A patent/JP2001031554A/en active Pending
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2008169219A (en) * | 2000-02-25 | 2008-07-24 | Kuhs Gmbh | Cosmetic composition |
| WO2001093855A1 (en) * | 2000-06-07 | 2001-12-13 | Otsuka Kagaku Kabushiki Kaisha | Skin-moistening compositions and skin-moistening foods |
| JP2004238285A (en) * | 2000-06-07 | 2004-08-26 | Otsuka Chemical Holdings Co Ltd | Composition for moisture retention of skin and food for moisture retention of skin |
| JP2007001950A (en) * | 2005-06-27 | 2007-01-11 | Pola Chem Ind Inc | Ceramide-containing skin external preparation |
| JP2013227294A (en) * | 2012-03-30 | 2013-11-07 | Kose Corp | Translucent to transparent composition |
| JP2017014202A (en) * | 2015-06-30 | 2017-01-19 | 株式会社コーセー | Cosmetic |
| JP7075177B2 (en) | 2015-06-30 | 2022-05-25 | 株式会社コーセー | Cosmetics |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2000327552A (en) | Skin preparation for external use | |
| EP0633763B1 (en) | Cosmetical or pharmaceutical compositions comprising deacylated glycerophospholipids for topical use | |
| JP2000229832A (en) | Skin lotion | |
| JPH07277939A (en) | Skin external preparation | |
| JPH07300412A (en) | Active oxygen remover and composition containing the same | |
| JP3513872B2 (en) | External preparation for skin | |
| JPH11193207A (en) | Preparation for external use for skin | |
| JP2000016917A (en) | Skin whitening cosmetic | |
| JP2004002289A (en) | Parakeratosis inhibitor | |
| JPH0782131A (en) | Hyaluronidase activity inhibitor and oil in water type cream base preparation | |
| JPH0532556A (en) | Skin agent for external use | |
| JP2001031554A (en) | Preparation for external use for skin | |
| KR101761005B1 (en) | Cosmetic composition containing non-toxic sulfur for sikn moisture, anti-inflammatory and immune enhancement and manufacturing the same | |
| JPH11269034A (en) | Skin prepafation for external use for improving acne | |
| JPH0745387B2 (en) | Hair growth and hair growth promoter | |
| JPH06128142A (en) | External agent for skin | |
| JP3568983B2 (en) | Hair restorer | |
| JPH05155738A (en) | Hair-tonic | |
| JP2694756B2 (en) | Cosmetics containing divalent and trivalent iron salts | |
| JP3101090B2 (en) | External preparation for skin | |
| JP3513861B2 (en) | External preparation for skin | |
| JP3441387B2 (en) | Moisturizer, skin cosmetics and bath additives | |
| JP2855274B2 (en) | Hair restoration | |
| JP3712673B2 (en) | Gel composition and oil-in-water (O / W) type composition | |
| JPH09176030A (en) | Sebum secretagogue |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20041007 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20041027 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20041222 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20050126 |